2021 Revenues ($USD) : $5,748,660,798
2021 Revenues (foreign currencies) : ¥613,842,000,000
2021 R&D spend : $459,786,477
2021 Number of Employees : 26,000
Fiscal Year End : 3/31/2021
Key People : Shinjiro Sato, president and CEO; Takayoshi Mimura, chair.

About the company: Terumo is one of the few medical device companies with roots stretching back one century. Beginning life as a thermometer manufacturer, Terumo has a diversified range of products spanning interventional cardiology, blood transfusion and cell therapy. In addition to its presence in Asia, the Tokyo-based company has subsidiaries in the EMEA region, South America and North America. Since the mid-1990s, the company has developed devices for transradial intervention, a technique involving the insertion of a catheter in the wrist to grant blood vessel access.  It also makes devices for diabetes care and peritoneal dialysis treatments. In total, the company offers 50,000 products and services. –BB